Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
Pfizer Inc.
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{Infobox company | name = Pfizer Inc. | logo = Pfizer (2021).svg | logo_size = 250px | type = [[Public company|Public]] | traded_as = {{ubl|{{New York Stock Exchange|PFE}}|[[S&P 100]] component|[[S&P 500]] component}} | founders = {{ubl|[[Charles Pfizer]]|[[Charles F. Erhart]]}} | founded = {{start date and age|1849}} in [[New York City]] | industry = {{Unbulleted list|[[Pharmaceutical industry|Pharmaceutical]]|[[Biotechnology]]}} | hq_location = [[The Spiral (New York City)|The Spiral]] | hq_location_city = New York City | hq_location_country = U.S. | area_served = Worldwide | key_people = [[Albert Bourla]] ([[CEO]]) | products = {{hlist|[[Medication|Pharmaceutical drugs]]|[[vaccine]]s}} | revenue = {{increase}} {{US$|100.3}}{{nbsp}}billion | revenue_year = 2022 | operating_income = {{increase}} {{US$|31.40}}{{nbsp}}billion | income_year = 2022 | net_income = {{increase}} {{US$|31.37}}{{nbsp}}billion | net_income_year = 2022 | assets = {{increase}} {{US$|197.2}}{{nbsp}}billion | assets_year = 2022 | equity = {{increase}} {{US$|95.66}}{{nbsp}}billion | equity_year = 2022 | num_employees = {{circa|83,000}} | num_employees_year = 2022 | website = {{url|pfizer.com/}} | footnotes = <ref name=10K>{{cite web |url=https://www.sec.gov/ix?doc=/Archives/edgar/data/78003/000007800323000024/pfe-20221231.htm |title=Pfizer Inc. 2022 Form 10-K Annual Report |publisher=[[U.S. Securities and Exchange Commission]] |date=February 23, 2023}}</ref> }} Pfizer Inc., a pioneering biopharmaceutical powerhouse, boasts an extensive operational footprint that spans across more than 150 countries globally. This intricate network encompasses an array of cutting-edge manufacturing plants and innovative research and development (R&D) centers. This sprawling infrastructure empowers Pfizer to not only engage in groundbreaking scientific exploration but also to orchestrate the seamless production of its diverse product portfolio. Central to Pfizer's operational prowess is its masterful supply chain management, a linchpin in the company's global operations. Facilitating the distribution of a wide spectrum of offerings—ranging from groundbreaking medical breakthroughs and revolutionary vaccines to products catering to consumer health and animal well-being—this intricate supply chain network connects healthcare professionals and patients on a global scale. Leveraging state-of-the-art technologies and strategic acumen, Pfizer navigates the intricate web of supply chain intricacies with unparalleled efficiency. Engrained in Pfizer's DNA is an unwavering commitment to quality control, exemplified by its strict adherence to internationally recognized benchmarks like the esteemed Good Manufacturing Practices (GMP). Each facet of Pfizer's operational lifecycle, commencing from the inception of groundbreaking R&D initiatives to the culmination of product dispatch, is subjected to meticulous scrutiny in alignment with these rigorous standards. Routine audits and comprehensive inspections are seamlessly integrated into the operational framework to ensure a steadfast commitment to quality benchmarks and to catalyze an ongoing trajectory of process enhancement.
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)